Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -3,984 | -13,180 |
| Depreciation Amortization | 144 | 490 |
| Accounts receivable | -1,063 | N/A |
| Accounts payable and accrued liabilities | 839 | N/A |
| Other Working Capital | -1,293 | -10 |
| Other Operating Activity | 567 | 280 |
| Operating Cash Flow | $-4,790 | $-12,420 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 2,000 | N/A |
| PPE Investments | -289 | -420 |
| Other Investing Activity | 0 | -2,000 |
| Investing Cash Flow | $1,711 | $-2,420 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 8,991 | N/A |
| Debt Repayment | -600 | N/A |
| Other Financing Activity | 0 | 12,770 |
| Financing Cash Flow | $8,391 | $12,770 |
| Beginning Cash Position | 2,215 | 4,280 |
| End Cash Position | 7,527 | 2,210 |
| Net Cash Flow | $5,312 | $-2,070 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,790 | -12,420 |
| Capital Expenditure | -289 | N/A |
| Free Cash Flow | -5,079 | -12,420 |